Results 1 to 10 of about 14,299,063 (394)

Acquired Factor VIII Deficiency Presenting as Gross Hematuria in a Hispanic, Pregnant Patient with Previously Undiagnosed Connective Tissue Disease [PDF]

Case Reports in Rheumatology, 2021
Acquired factor VIII deficiency is a bleeding disorder caused by the presence of autoantibodies against clotting factor VIII. We report a case of a 24-year-old pregnant woman who presented with gross hematuria secondary to acquired factor VIII deficiency
Dulgheru, Emilia C., Loftis, Christine, White, Rosa   +2 more
core   +3 more sources

Desmopressin in moderate hemophilia a patients: A treatment worth considering [PDF]

Haematologica, 2018
Desmopressin increases endogenous factor VIII levels in hemophilia A. Large inter-individual variation in the response to desmopressin is observed.
Beckers, E., Bom, J.G. van der, Carcao, M., Fijnvandraat, K., Jackson, S., Kruip, M.J.H.A., Loomans, J.I., Peters, M., Platokouki, H., RISE Consortium, Santagostino, E., Velzen, A.S. van, Voorberg, J.   +12 more
core   +5 more sources

Minimal dataset for post-registration surveillance of new drugs in hemophilia: communication from the SSC of the ISTH [PDF]

, 2017
Clinical ...
Collins, P., Iorio, A., Lillicrap, D., Makris, M., Peyvandi, F., Pipe, S.W., Rosendaal, F.R., Subcomm Factor VIII Factor IX   +7 more
core   +3 more sources

Prolonged elevations in haemostatic and rheological responses following psychological stress in low socioeconomic status men and women [PDF]

, 2003
Low socioeconomic status (SES) and psychological stress are associated with increased risk of coronary heart disease, and both may influence haemostatic responses.
Kunz-Ebrecht, S., Lowe, G.D.O., Rumley, A., Steptoe, A.   +3 more
core   +1 more source

Spontaneous bleeding in a patient with malignant lymphoma: A case of acquired hemophilia [PDF]

, 2000
Background: Acquired hemophilia is a rare condition which can be associated with lymphoproliferative disease. Case Report: Eleven yea rs after the diagnosis of immunocytoma had been made, a 72-year-old man developed a high-titer factor VIII inhibitor. At
Brack, N., Geiersberger, U., Gesierich, Wolfgang, Hartenstein, R., Munker, Reinhold, Pohlmann, H.   +5 more
core   +1 more source

Successful elimination of factor VIII inhibitor using cyclosporin A [PDF]

, 2003
No abstract ...
Dykes, Gordon D. O. Lowe, Grunewald, Hay, Isobel D. Walker, Lian, Mark D. McColl, Morrison, Peter S. Maclean, Pfliegler, R. Campbell Tait   +10 more
core   +1 more source

Isolation and primary cultures of human intrahepatic bile ductular epithelium [PDF]

, 1988
A technique for the isolation of human intrahepatic bile ductular epithelium, and the establishment of primary cultures using a serum- and growth-factor-supplemented medium combined with a connective tissue substrata is described.
A. E. Sirica, A. G. Grant, A. J. Demetris, A. J. Demetris, A. J. Demetris, B. H. Markus, C. Petropoulos, D. C. Snover, H. O. Jauregni, H. Yoshimura, J. J. Fung, J. W. Grisham, J. W. Grisham, J. W. Grisham, L. M. Ried, L. Makowka, N. Fausto, N. T. Hayner, R. Duquesnoy, R. N. M. MacSween, S. Graner, S. L. Hammond, S. Saidman, T. E. Starzl, T. Ming-Sound   +24 more
core   +1 more source

The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men [PDF]

, 2003
Light to moderate drinking is associated with lower risk of coronary heart (CHD) than non-drinkers. We have examined the relationships between total alcohol intake and type of alcoholic beverage and several potential biological mechanisms. We carried out
Lennon, L., Lowe, G.D.O., Rumley, A., Shaper, G., Walker, M., Wannamethee, S.G., Whincup, P.H.   +6 more
core   +1 more source

Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial):an open-label, multicentre, randomised, controlled trial [PDF]

, 2021
Background Dosing of replacement therapy with factor VIII concentrate in patients with haemophilia A in the perioperative setting is challenging. Underdosing and overdosing of factor VIII concentrate should be avoided to minimise risk of perioperative ...
Beckers, E.A., Bom, J.G. van der, Brons, P.P., Bukkems, L.H., Cnossen, M.H., Coppens, M., Fijnvandraat, K., Hazendonk, H., Laros-van Gorkom, B.A.P., Leebeek, F.W.G., Mathôt, R.A.A., Meer, F.J. van der, Meijer, K, Moort, I. van, Nieuwenhuizen, L., Preijers, T., Schols, S.E.M., Schutgens, R.E., Ypma, P.   +18 more
core   +1 more source

Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia [PDF]

, 2017
The most worrying complication of replacement therapy for severe hemophilia A and B is currently the occurrence of inhibitory alloantibodies against infused factor VIII and factor IX, respectively.
Franchini, Massimo, Liumbruno, Giancarlo Maria, Marano, Giuseppe, Mengoli, Carlo, Piccinini, Vanessa, Pupella, Simonetta, Vaglio, Stefania   +6 more
core   +1 more source